| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 6002- | CGA, | Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 6013- | CGA, | Advances in Pharmacological Properties, Molecular Mechanisms, and Bioavailability Strategies of Chlorogenic Acid in Cardiovascular Diseases Therapy |
| - | Review, | CardioV, | NA |
| 6008- | CGA, | Risk Assessment of Chlorogenic and Isochlorogenic Acids in Coffee By-Products |
| - | Review, | Nor, | NA |
| 6038- | CGA, | Neuromodulation and neuroprotective effects of chlorogenic acids in excitatory synapses of mouse hippocampal slices |
| - | in-vivo, | AD, | NA | - | in-vivo, | Stroke, | NA |
| 6037- | CGA, | Pharmacokinetics and brain penetration study of chlorogenic acid in rats |
| - | in-vivo, | AD, | NA | - | in-vivo, | Stroke, | NA |
| 6036- | CGA, | Effect of Chlorogenic Acids on Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | Nor, | NA |
| 6034- | CGA, | Effect and mechanism of chlorogenic acid on cognitive dysfunction in mice by lipopolysaccharide-induced neuroinflammation |
| - | in-vivo, | AD, | NA |
| - | in-vivo, | AD, | NA |
| 1244- | CGA, | immuno, | Cancer Differentiation Inducer Chlorogenic Acid Suppresses PD-L1 Expression and Boosts Antitumor Immunity of PD-1 Antibody |
| - | in-vivo, | NA, | NA |
| 6630- | CGA, | In Vitro and In Silico Study on the Impact of Chlorogenic Acid in Colorectal Cancer Cells: Proliferation, Apoptosis, and Interaction with β-Catenin and LRP6 |
| - | in-vitro, | CRC, | HT29 | - | in-vitro, | CRC, | SW480 |
| 7183- | CHA, | The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells |
| - | in-vitro, | AML, | HL-60 | - | in-vitro, | AML, | KG-1 | - | in-vitro, | lymphoma, | U937 |
| 7184- | CHA, | Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance |
| - | in-vitro, | CML, | NA |
| 7186- | CHA, | TSA, | Improved Therapeutic Effect against Leukemia by a Combination of the Histone Methyltransferase Inhibitor Chaetocin and the Histone Deacetylase Inhibitor Trichostatin A |
| - | in-vitro, | AML, | NA |
| 7171- | CHA, | Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201 |
| - | vitro+vivo, | GBM, | DIPG |
| 7168- | CHA, | The anticancer effect of chaetocin is enhanced by inhibition of autophagy |
| - | vitro+vivo, | Liver, | HepG2 | - | in-vitro, | Liver, | HepG3 | - | in-vitro, | Liver, | HUH7 |
| 7166- | CHA, | Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1 |
| - | vitro+vivo, | AML, | U937 |
| 7165- | CHA, | The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase |
| - | in-vitro, | Cerv, | HeLa |
| 7164- | CHA, | Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo |
| - | vitro+vivo, | Melanoma, | A375 |
| 7163- | CHA, | The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | OS, | U2OS | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HeLa | - | in-vivo, | Ovarian, | SKOV3 |
| 7160- | CHA, | Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress |
| - | in-vitro, | Lung, | A549 |
| 7159- | CHA, | ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin |
| - | vitro+vivo, | GC, | HGC27 | - | in-vitro, | GC, | AGS | - | in-vitro, | GC, | BGC-823 | - | in-vitro, | GC, | SGC-7901 | - | in-vitro, | Nor, | HEK293 |
| 2175- | Chemo, | VitB12, | FA, | Systemic Chemotherapy Interferes in Homocysteine Metabolism in Breast Cancer Patients |
| - | Study, | BC, | NA |
| 6025- | Chit, | Glycated chitosan as a new non-toxic immunological stimulant |
| - | vitro+vivo, | Var, | HeLa |
| 6000- | Chit, | Chitosan in Modern Pharmacotherapy: From Drug Encapsulation to Targeted Delivery Systems |
| - | Review, | Var, | NA |
| 6001- | Chit, | Recent advances in engineering chitosan-based nanoplatforms in biotherapeutic multi-delivery for multi-targeted disease treatments: Promises and outlooks |
| - | Review, | Var, | HepG2 | - | Review, | AD, | NA |
| 5981- | Chit, | Chitosan-Based Drug Delivery Systems for Targeted Chemotherapy in Colorectal Cancer: A Scoping Review |
| - | Review, | CRC, | NA |
| 5984- | Chit, | Chitosan in cancer therapy: a dual role as a therapeutic agent and drug delivery system |
| - | Review, | Var, | NA |
| 5985- | Chit, | immuno, | Immunomodulatory potential of chitosan-based materials for cancer therapy: a systematic review of in vitro, in vivo and clinical studies. |
| - | Review, | Var, | NA |
| 5987- | Chit, | Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine |
| - | Review, | Var, | NA |
| 5991- | Chit, | Chitosan-Based Nanoencapsulated Essential Oils: Potential Leads against Breast Cancer Cells in Preclinical Studies |
| - | Review, | BC, | NA |
| 5999- | Chit, | How chitosan can help against breast cancer |
| - | Review, | BC, | NA |
| 5997- | Chit, | Using immunoadjuvant agent glycated chitosan to enhance anti-cancer stem like cell immunity induced by HIFU |
| - | in-vivo, | Lung, | NA |
| 5996- | Chit, | NEW CHITOSAN-BASED CHEMO PHARMACEUTICAL DELIVERY SYSTEMS FOR TUMOR CANCER TREATMENT: SHORT-REVIEW |
| - | Review, | Var, | NA |
| 5995- | Chit, | CUR, | Enhancement of anticancer activity and drug delivery of chitosan-curcumin nanoparticle via molecular docking and simulation analysis |
| - | vitro+vivo, | Var, | NA |
| 5994- | Chit, | Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action |
| - | Review, | Var, | NA |
| 5992- | Chit, | Preparation of chitosan nanoparticles for simultaneous drug delivery of dacarbazine and enoxaparin in melanoma |
| - | in-vitro, | Melanoma, | B16-F10 |
| 5990- | Chit, | Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies |
| - | Review, | Var, | NA |
| 4477- | Chit, | Recent Advances in Chitosan and its Derivatives in Cancer Treatment |
| - | Review, | NA, | NA |
| 4479- | Chit, | Chitosan nanoparticles triggered the induction of ROS-mediated cytoprotective autophagy in cancer cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | HCC, | SMMC-7721 cell |
| 4490- | Chit, | FA, | Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives |
| - | Review, | NA, | NA |
| 4489- | Chit, | SeNPs, | Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy |
| - | in-vitro, | GBM, | U87MG |
| 6078- | CHL, | Update on the bioavailability and chemopreventative mechanisms of dietary chlorophyll derivatives |
| - | Review, | Nor, | NA |
| 6073- | CHL, | GEM, | Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis |
| - | in-vitro, | PC, | NA |
| 6065- | CHL, | Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin |
| - | Review, | HCC, | NA |
| - | vitro+vivo, | BC, | 4T1 |
| 6077- | CHL, | Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose-dose matrix biomarker and tumor study |
| - | in-vivo, | Var, | NA |
| 6079- | CHL, | Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice |
| - | in-vivo, | Nor, | NA |
| 6069- | CHL, | PDT, | Anti-Cancer Effect of Chlorophyllin-Assisted Photodynamic Therapy to Induce Apoptosis through Oxidative Stress on Human Cervical Cancer |
| - | in-vitro, | Cerv, | HeLa |
| 6076- | CHL, | Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers |
| - | Human, | Nor, | NA |
| 6093- | CHOC, | The relevance of theobromine for the beneficial effects of cocoa consumption |
| - | Review, | Nor, | NA | - | NA, | Asthma, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid